Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma in Situ × Mastectomy, Subcutaneous × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 10 Li-Fraumeni Syndrome 1 Hamartoma Syndrome, Multiple 1 Endoscopic Subcutaneous Mastectomy 1 Cystic Fibrosis 1 Carcinoma, Ductal 1 Carcinoma in Situ 1 Breast Carcinoma In Situ 1

Interventions

valrubicin 3 dodecyl maltoside 3 Magnetic Resonance Imaging 3 Gemcitabine 3 durvalumab 2 Mitomycin 2 Interferon beta-1b 2 Electrocardiography 2 Diphenhydramine 2 Cystoscopy 2 Biopsy 2 Acetaminophen 2 toripalimab 1 pembrolizumab 1 fludarabine phosphate 1 fludarabine 1 enfortumab vedotin 1 cemiplimab 1 apaziquone 1 aldesleukin 1 advexin 1 Tomography, X-Ray Computed 1 Surveys and Questionnaires 1 Standard of Care 1 Sampling Studies 1 Respiratory Function Tests 1 Proflavine 1 Prochlorperazine 1 Positron-Emission Tomography 1 Physical Examination 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02311959 2024-12-24

MAPAM-01

Institut Claudius Regaud

Phase 3 Completed

Breast Neoplasms, Carcinoma in Situ

Data powered by HemOnc (CC BY 4.0) Colophon ⚡